Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.22 billion.
Market Cap
1.12T
Revenue
105.22B
Profits
-42.54B
PE Ratio
n/a
Profit Margin
-40.43%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.06B | -3.03% | 1,464,711 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.11B | -2.16% | 939,903 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 56.81B | -6.14% | 2,385,936 | 3.21B |
| 4 | ARGX | argenx SE | 54.89B | -0.06% | 393,949 | 3.68B |
| 5 | INSM | Insmed Incorporated | 41.90B | -3.69% | 3,500,055 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 36.15B | 1.16% | 251,213 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.40B | 1.11% | 1,569,886 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.30B | -2.76% | 4,336,127 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.70B | 0.43% | 1,481,714 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.97B | -5.75% | 3,875,493 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.49B | 0.62% | 2,262,064 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.60B | 0.10% | 5,831,780 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.36B | 1.72% | 3,175,100 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.32B | 0.88% | 1,550,853 | 353.78M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.19B | -0.27% | 1,465,094 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.84B | -2.07% | 332,211 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.71B | 1.24% | 589,541 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.36B | -4.85% | 3,663,738 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 10.93B | 0.97% | 10,883,763 | 2.23B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.74B | -0.45% | 3,449,950 | 20.87M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.27B | -0.42% | 863,109 | 4.16B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.24B | -0.21% | 1,957,981 | 3.09B |
| 23 | TECH | Bio-Techne Corporation | 9.39B | -2.27% | 2,069,238 | 1.22B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.30B | 11.43% | 4,253,166 | 829.45M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.77B | 0.55% | 919,900 | 7.07M |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.72B | -3.77% | 882,320 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 8.38B | -1.54% | 717,231 | - |
| 28 | CAI | Caris Life Sciences, Inc. | 8.02B | -1.52% | 2,204,697 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 7.84B | -2.30% | 1,492,839 | 87.21M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.48B | -0.55% | 447,066 | 561.26M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.39B | -0.76% | 1,897,952 | 1.24B |
| 32 | MRUS | Merus N.V. | 7.30B | 0.10% | 588,771 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.01B | 0.48% | 424,978 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.92B | -0.12% | 1,670,264 | 302.00K |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.79B | 41.67% | 7,441,156 | 43.74M |
| 36 | KRYS | Krystal Biotech, Inc. | 6.79B | -0.06% | 439,020 | 373.16M |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 6.78B | 9.26% | 1,547,716 | 7.46M |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.17B | -0.49% | 950,776 | 1.78B |
| 39 | COGT | Cogent Biosciences, Inc. | 6.13B | 4.00% | 4,866,731 | - |
| 40 | PCVX | Vaxcyte, Inc. | 6.05B | -0.60% | 1,089,190 | - |
| 41 | PTGX | Protagonist Therapeutics, Inc. | 5.63B | 0.44% | 1,278,522 | 209.22M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.46B | 0.76% | 1,303,272 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.19B | -0.81% | 125,755 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.13B | -0.95% | 1,474,633 | - |
| 45 | LEGN | Legend Biotech Corporation | 4.84B | -6.93% | 9,370,147 | 909.05M |
| 46 | CELC | Celcuity Inc. | 4.82B | -1.44% | 1,058,608 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.62B | 0.67% | 1,252,816 | - |
| 48 | ADMA | ADMA Biologics, Inc. | 4.61B | -2.32% | 3,214,459 | 488.56M |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.52B | -2.55% | 1,614,314 | 1.05B |
| 50 | TGTX | TG Therapeutics, Inc. | 4.51B | 0.20% | 1,160,159 | 531.90M |
| 51 | AKRO | Akero Therapeutics, Inc. | 4.50B | 0.20% | 14,910,209 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.49B | 1.33% | 1,342,655 | 1.54M |
| 53 | CNTA | Centessa Pharmaceuticals plc | 4.30B | -1.52% | 743,926 | 15.00M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.30B | -1.32% | 5,040,125 | - |
| 55 | ACLX | Arcellx, Inc. | 4.28B | 6.44% | 3,897,240 | 35.90M |
| 56 | GPCR | Structure Therapeutics Inc. | 4.25B | 102.49% | 19,338,559 | - |
| 57 | IMVT | Immunovant, Inc. | 4.06B | 1.40% | 1,240,987 | - |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 4.05B | 1.39% | 916,644 | 35.24M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.80B | -0.48% | 1,924,472 | 317.93M |
| 60 | TERN | Terns Pharmaceuticals, Inc. | 3.62B | 36.82% | 13,476,863 | - |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.51B | 0.29% | 1,654,921 | 630.60M |
| 62 | MIRM | Mirum Pharmaceuticals, Inc. | 3.49B | -0.80% | 1,614,422 | 471.79M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.49B | 0.57% | 464,084 | 366.10M |
| 64 | IRON | Disc Medicine, Inc. | 3.47B | -1.42% | 628,843 | - |
| 65 | CGON | CG Oncology, Inc. | 3.46B | -1.02% | 519,703 | 2.17M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.44B | -1.14% | 970,509 | 7.50M |
| 67 | OCUL | Ocular Therapeutix, Inc. | 3.43B | 28.10% | 16,910,762 | 55.78M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.28B | -2.08% | 73,100 | 664.23M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.20B | 1.61% | 1,300,171 | 240.00M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.17B | 9.37% | 8,047,223 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.10B | -1.51% | 1,459,826 | 214.83M |
| 72 | WVE | Wave Life Sciences Ltd. | 3.10B | 147.33% | 144,693,746 | 109.23M |
| 73 | TVTX | Travere Therapeutics, Inc. | 3.06B | -2.20% | 1,539,441 | 435.83M |
| 74 | LQDA | Liquidia Corporation | 3.04B | 1.71% | 1,420,076 | 69.22M |
| 75 | VRDN | Viridian Therapeutics, Inc. | 3.04B | -0.50% | 968,149 | 70.79M |
| 76 | FOLD | Amicus Therapeutics, Inc. | 3.04B | -0.61% | 3,137,835 | 598.70M |
| 77 | MLYS | Mineralys Therapeutics, Inc. | 3.03B | -0.62% | 880,116 | - |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 3.01B | 0.72% | 2,961,365 | 1.02B |
| 79 | NUVB | Nuvation Bio Inc. | 2.95B | 0.53% | 7,563,724 | 26.75M |
| 80 | AAPG | Ascentage Pharma Group International | 2.94B | -4.44% | 3,186 | 54.52M |
| 81 | DNLI | Denali Therapeutics Inc. | 2.89B | -1.35% | 1,462,437 | - |
| 82 | VERA | Vera Therapeutics, Inc. | 2.88B | 0.27% | 1,955,878 | - |
| 83 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.84B | -1.64% | 1,034,697 | 578.20M |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.75B | -0.42% | 1,623,928 | 98.68M |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.69B | 3.56% | 1,178,635 | - |
| 86 | BEAM | Beam Therapeutics Inc. | 2.67B | 0.02% | 1,527,400 | 55.70M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.52B | 2.44% | 34,645,863 | 43.69M |
| 88 | EWTX | Edgewise Therapeutics, Inc. | 2.49B | -0.38% | 1,294,260 | - |
| 89 | MESO | Mesoblast Limited | 2.32B | 1.51% | 179,822 | 17.20M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.30B | -1.53% | 3,807,300 | 2.41B |
| 91 | ADPT | Adaptive Biotechnologies Corporation | 2.28B | 1.22% | 3,737,985 | 252.75M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -2.28% | 874,940 | 825.94M |
| 93 | IBRX | ImmunityBio, Inc. | 2.22B | -1.53% | 10,301,408 | 82.56M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 2.20B | 2.98% | 1,838,642 | - |
| 95 | NRIX | Nurix Therapeutics, Inc. | 2.18B | 18.74% | 6,060,364 | 83.69M |
| 96 | ZBIO | Zenas BioPharma, Inc. | 2.13B | 0.81% | 303,894 | 15.00M |
| 97 | ZLAB | Zai Lab Limited | 2.12B | -2.28% | 884,991 | 441.63M |
| 98 | GLPG | Galapagos NV | 2.07B | -0.38% | 79,591 | 336.64M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.10% | 1,820,591 | 265.81M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.99B | -0.65% | 414,222 | 2.50M |
| 101 | CLDX | Celldex Therapeutics, Inc. | 1.98B | 1.09% | 1,089,679 | 2.60M |
| 102 | ZYME | Zymeworks Inc. | 1.98B | -0.97% | 554,583 | 134.48M |
| 103 | IMCR | Immunocore Holdings plc | 1.92B | -1.83% | 154,431 | 379.59M |
| 104 | VCEL | Vericel Corporation | 1.88B | 2.84% | 1,028,570 | 258.72M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.88B | 6.45% | 788,142 | 205.63M |
| 106 | DNTH | Dianthus Therapeutics, Inc. | 1.87B | -1.63% | 416,723 | 3.08M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.84B | 2.36% | 204,980 | - |
| 108 | IMNM | Immunome, Inc. | 1.80B | -0.46% | 931,694 | 9.68M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -1.48% | 2,292,063 | 111.30M |
| 110 | MNKD | MannKind Corporation | 1.72B | -1.41% | 2,546,225 | 313.79M |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.66B | -3.71% | 1,868,195 | - |
| 112 | CAPR | Capricor Therapeutics, Inc. | 1.65B | 6.21% | 5,311,150 | 11.13M |
| 113 | PHVS | Pharvaris N.V. | 1.64B | -4.24% | 327,568 | - |
| 114 | ATAI | Atai Beckley N.V. | 1.62B | 3.12% | 2,215,125 | 3.02M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -1.77% | 924,343 | 44.79M |
| 116 | INVA | Innoviva, Inc. | 1.57B | 1.25% | 912,546 | 388.52M |
| 117 | SVRA | Savara Inc. | 1.57B | -0.08% | 2,325,469 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.57B | 4.40% | 344,709 | 2.80M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.51B | 1.48% | 387,874 | - |
| 120 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | -3.73% | 1,036,723 | -665.00K |
| 121 | TSHA | Taysha Gene Therapies, Inc. | 1.49B | 7.72% | 4,018,788 | 6.31M |
| 122 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.48B | 0.51% | 1,279,605 | 42.34M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 2.14% | 283,832 | - |
| 124 | ARDX | Ardelyx, Inc. | 1.42B | -2.01% | 2,705,317 | 398.23M |
| 125 | MBX | MBX Biosciences, Inc. | 1.41B | -1.85% | 599,118 | - |
| 126 | BHVN | Biohaven Ltd. | 1.40B | 10.58% | 2,975,234 | - |
| 127 | KOD | Kodiak Sciences Inc. | 1.38B | 7.23% | 743,168 | - |
| 128 | FTRE | Fortrea Holdings Inc. | 1.37B | 3.97% | 1,859,959 | 2.76B |
| 129 | QURE | uniQure N.V. | 1.36B | 2.34% | 2,582,922 | 15.75M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.36B | 4.36% | 198,103 | 1.40M |
| 131 | RLAY | Relay Therapeutics, Inc. | 1.32B | -0.59% | 1,066,701 | 8.36M |
| 132 | PGEN | Precigen, Inc. | 1.31B | 2.64% | 1,719,301 | 6.31M |
| 133 | TNGX | Tango Therapeutics, Inc. | 1.29B | -0.52% | 1,577,951 | 66.50M |
| 134 | MNMD | Mind Medicine (MindMed) Inc. | 1.28B | 4.94% | 3,944,126 | - |
| 135 | XNCR | Xencor, Inc. | 1.26B | 2.14% | 699,929 | 150.13M |
| 136 | IMTX | Immatics N.V. | 1.25B | 1.18% | 636,946 | 99.45M |
| 137 | ANAB | AnaptysBio, Inc. | 1.23B | 0.43% | 300,429 | 169.47M |
| 138 | SANA | Sana Biotechnology, Inc. | 1.23B | -9.84% | 5,029,120 | - |
| 139 | ELVN | Enliven Therapeutics, Inc. | 1.22B | -5.82% | 423,643 | - |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.21B | 5.81% | 424,387 | - |
| 141 | PVLA | Palvella Therapeutics, Inc. | 1.20B | 0.56% | 177,591 | - |
| 142 | OCS | Oculis Holding AG | 1.19B | -5.21% | 94,923 | 992.00K |
| 143 | CVAC | CureVac N.V. | 1.17B | 1.76% | 760,928 | 83.00M |
| 144 | NKTR | Nektar Therapeutics | 1.16B | 0.53% | 406,480 | 62.60M |
| 145 | SEPN | Septerna, Inc. | 1.16B | -2.97% | 423,126 | 22.05M |
| 146 | GLUE | Monte Rosa Therapeutics, Inc. | 1.16B | 2.53% | 874,828 | 181.54M |
| 147 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | 7.30% | 2,630,582 | 266.14M |
| 148 | ALMS | Alumis Inc. | 1.16B | -0.31% | 1,890,793 | 22.12M |
| 149 | PHAR | Pharming Group N.V. | 1.12B | - | 29,243 | 362.27M |
| 150 | NVAX | Novavax, Inc. | 1.10B | -2.17% | 3,170,868 | 1.06B |
| 151 | NTLA | Intellia Therapeutics, Inc. | 1.09B | -1.93% | 3,446,777 | 57.53M |
| 152 | YDES | YD Bio Limited | 1.09B | 11.11% | 125,714 | 510.36K |
| 153 | URGN | UroGen Pharma Ltd. | 1.08B | 0.57% | 502,317 | 96.52M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.08B | 1.12% | 2,513,044 | 35.33M |
| 155 | MLTX | MoonLake Immunotherapeutics | 1.08B | 1.28% | 2,571,239 | - |
| 156 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.06B | -3.21% | 168,400 | - |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 2.19% | 726,915 | 147.19M |
| 158 | AVBP | ArriVent BioPharma, Inc. | 1.03B | 1.50% | 407,437 | - |
| 159 | BCAX | Bicara Therapeutics Inc. | 1.03B | 3.35% | 406,946 | - |
| 160 | NBTX | Nanobiotix S.A. | 1.03B | -0.52% | 24,603 | 11.93M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -4.82% | 2,042,053 | - |
| 162 | KURA | Kura Oncology, Inc. | 1.01B | -2.68% | 1,394,852 | 104.03M |
| 163 | JANX | Janux Therapeutics, Inc. | 996.65M | 0.36% | 2,635,173 | 10.00M |
| 164 | MDXG | MiMedx Group, Inc. | 987.84M | -3.75% | 1,036,919 | 393.44M |
| 165 | SPRY | ARS Pharmaceuticals, Inc. | 987.00M | 0.55% | 1,128,999 | 142.77M |
| 166 | RAPT | RAPT Therapeutics, Inc. | 968.49M | 1.41% | 415,798 | - |
| 167 | CMPX | Compass Therapeutics, Inc. | 953.34M | -3.07% | 1,247,082 | 850.00K |
| 168 | RZLT | Rezolute, Inc. | 943.04M | -2.40% | 2,601,722 | - |
| 169 | ERAS | Erasca, Inc. | 940.50M | 1.38% | 1,790,640 | - |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 930.77M | -1.62% | 1,312,613 | 192.44M |
| 171 | VIR | Vir Biotechnology, Inc. | 918.92M | 1.62% | 1,917,577 | 16.86M |
| 172 | TBPH | Theravance Biopharma, Inc. | 917.68M | -2.37% | 302,974 | 80.33M |
| 173 | GHRS | GH Research PLC | 916.17M | -0.81% | 161,949 | - |
| 174 | IOVA | Iovance Biotherapeutics, Inc. | 915.01M | 4.77% | 12,113,548 | 250.43M |
| 175 | CRMD | CorMedix Inc. | 887.56M | 6.68% | 2,974,369 | 214.30M |
| 176 | DAWN | Day One Biopharmaceuticals, Inc. | 879.42M | 8.14% | 9,670,941 | 133.67M |
| 177 | ABUS | Arbutus Biopharma Corporation | 865.46M | 1.81% | 764,143 | 14.61M |
| 178 | ARVN | Arvinas, Inc. | 853.54M | 3.91% | 1,289,446 | 312.30M |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 852.21M | 2.62% | 766,999 | 1.43M |
| 180 | REPL | Replimune Group, Inc. | 840.91M | 1.04% | 1,306,214 | - |
| 181 | LENZ | LENZ Therapeutics, Inc. | 835.44M | -0.07% | 725,441 | 17.50M |
| 182 | OMER | Omeros Corporation | 808.97M | 5.16% | 1,296,203 | - |
| 183 | GERN | Geron Corporation | 807.52M | -3.44% | 6,666,619 | 183.40M |
| 184 | MPLT | MapLight Therapeutics, Inc. | 797.33M | -1.19% | 358,839 | - |
| 185 | VSTM | Verastem, Inc. | 789.96M | -1.21% | 1,481,176 | 13.38M |
| 186 | GOSS | Gossamer Bio, Inc. | 789.27M | 2.40% | 1,816,943 | 44.05M |
| 187 | RIGL | Rigel Pharmaceuticals, Inc. | 788.31M | -11.22% | 1,002,598 | 282.08M |
| 188 | IVA | Inventiva S.A. | 776.73M | 4.12% | 125,172 | 19.93M |
| 189 | VALN | Valneva SE | 772.07M | 1.69% | 43,059 | 211.09M |
| 190 | GYRE | Gyre Therapeutics, Inc. | 741.67M | 2.26% | 125,487 | 107.27M |
| 191 | ATXS | Astria Therapeutics, Inc. | 741.53M | 0.46% | 944,264 | 706.00K |
| 192 | PRME | Prime Medicine, Inc. | 740.90M | 11.90% | 5,320,723 | 5.98M |
| 193 | CGEM | Cullinan Therapeutics, Inc. | 733.14M | 17.19% | 2,925,383 | - |
| 194 | ANNX | Annexon, Inc. | 721.43M | 4.99% | 2,369,909 | - |
| 195 | PROK | ProKidney Corp. | 712.98M | 1.28% | 1,116,022 | 744.00K |
| 196 | MGTX | MeiraGTx Holdings plc | 707.51M | 1.62% | 882,825 | 27.42M |
| 197 | FULC | Fulcrum Therapeutics, Inc. | 704.08M | 46.18% | 24,555,093 | 80.00M |
| 198 | LXEO | Lexeo Therapeutics, Inc. | 688.27M | 0.86% | 698,943 | - |
| 199 | RGNX | REGENXBIO Inc. | 668.48M | 0.34% | 491,738 | 161.32M |
| 200 | CTMX | CytomX Therapeutics, Inc. | 656.56M | -1.90% | 1,142,696 | 113.63M |
| 201 | CRVS | Corvus Pharmaceuticals, Inc. | 638.53M | -2.95% | 2,179,605 | - |
| 202 | FDMT | 4D Molecular Therapeutics, Inc. | 630.20M | 3.08% | 929,346 | 120.00K |
| 203 | VTYX | Ventyx Biosciences, Inc. | 627.96M | 0.92% | 1,851,829 | - |
| 204 | JBIO | Jade Biosciences, Inc. | 622.90M | 0.30% | 382,280 | - |
| 205 | LYEL | Lyell Immunopharma, Inc. | 612.57M | 14.34% | 58,959 | 41.00K |
| 206 | DRUG | Bright Minds Biosciences Inc. | 598.07M | 2.48% | 167,804 | - |
| 207 | ALT | Altimmune, Inc. | 586.40M | 7.25% | 5,450,041 | 20.00K |
| 208 | PRTA | Prothena Corporation plc | 579.75M | -2.71% | 561,846 | 11.79M |
| 209 | LBRX | LB Pharmaceuticals Inc | 576.06M | 16.77% | 411,785 | - |
| 210 | ASMB | Assembly Biosciences, Inc. | 564.04M | 1.86% | 191,542 | 37.19M |
| 211 | ENGN | enGene Holdings Inc. | 559.72M | 3.72% | 240,498 | - |
| 212 | DSGN | Design Therapeutics, Inc. | 559.38M | 0.51% | 224,002 | - |
| 213 | EVMN | Evommune, Inc. | 554.03M | -15.89% | 115,701 | 3.00M |
| 214 | IVVD | Invivyd, Inc. | 553.67M | 6.50% | 3,819,723 | 50.04M |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.82M | 2.11% | 995,723 | 180.61M |
| 216 | MNPR | Monopar Therapeutics Inc. | 522.11M | -2.80% | 192,329 | - |
| 217 | NAGE | Niagen Bioscience, Inc. | 518.98M | 0.47% | 646,117 | 124.71M |
| 218 | ABSI | Absci Corporation | 518.03M | -3.77% | 2,784,798 | 2.82M |
| 219 | BCYC | Bicycle Therapeutics plc | 510.55M | 4.10% | 281,176 | 28.34M |
| 220 | LXRX | Lexicon Pharmaceuticals, Inc. | 501.49M | -1.43% | 2,079,214 | 70.86M |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 493.17M | 0.57% | 881,226 | 84.39M |
| 222 | DBVT | DBV Technologies S.A. | 474.46M | 21.51% | 566,986 | 5.50M |
| 223 | NBP | NovaBridge Biosciences | 463.95M | -3.71% | 341,774 | - |
| 224 | DMAC | DiaMedica Therapeutics Inc. | 456.20M | -0.23% | 371,481 | - |
| 225 | BNTC | Benitec Biopharma Inc. | 446.13M | -2.98% | 134,090 | - |
| 226 | SLDB | Solid Biosciences Inc. | 443.70M | -1.30% | 671,729 | - |
| 227 | ANRO | Alto Neuroscience, Inc. | 434.00M | 4.02% | 374,870 | - |
| 228 | IMRX | Immuneering Corporation | 421.96M | 2.11% | 799,442 | - |
| 229 | AUTL | Autolus Therapeutics plc | 419.18M | 1.61% | 3,565,699 | 51.13M |
| 230 | TENX | Tenax Therapeutics, Inc. | 417.27M | 6.58% | 325,540 | - |
| 231 | KROS | Keros Therapeutics, Inc. | 416.08M | -1.71% | 1,069,893 | 246.72M |
| 232 | LCTX | Lineage Cell Therapeutics, Inc. | 410.75M | -1.45% | 711,342 | 10.82M |
| 233 | ENTA | Enanta Pharmaceuticals, Inc. | 409.85M | -2.74% | 317,439 | 65.32M |
| 234 | AURA | Aura Biosciences, Inc. | 406.10M | -0.54% | 127,447 | - |
| 235 | ADCT | ADC Therapeutics SA | 403.22M | -1.06% | 1,897,259 | 75.21M |
| 236 | PRTC | PureTech Health plc | 398.31M | -4.04% | 3,832 | 6.39M |
| 237 | TRDA | Entrada Therapeutics, Inc. | 395.19M | 6.78% | 153,871 | 61.52M |
| 238 | AVXL | Anavex Life Sciences Corp. | 387.32M | -1.48% | 1,525,717 | - |
| 239 | GALT | Galectin Therapeutics Inc. | 386.84M | 4.53% | 555,667 | - |
| 240 | PEPG | PepGen Inc. | 385.68M | 3.12% | 903,540 | - |
| 241 | XOMA | XOMA Royalty Corporation | 380.53M | 2.74% | 61,413 | 47.11M |
| 242 | RCKT | Rocket Pharmaceuticals, Inc. | 378.78M | 5.42% | 1,536,654 | - |
| 243 | VTVT | vTv Therapeutics Inc. | 378.47M | 11.52% | 10,146 | 17.00K |
| 244 | OCGN | Ocugen, Inc. | 376.35M | -1.23% | 2,670,043 | 5.37M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 374.23M | 0.38% | 199,672 | - |
| 246 | NMRA | Neumora Therapeutics, Inc. | 371.32M | -1.58% | 667,245 | - |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 363.44M | 14.10% | 2,520,599 | 212.07M |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 362.63M | 6.15% | 472,381 | - |
| 249 | FBRX | Forte Biosciences, Inc. | 361.27M | 1.66% | 53,434 | - |
| 250 | CTNM | Contineum Therapeutics, Inc. | 357.19M | 10.87% | 152,308 | - |
| 251 | ACRS | Aclaris Therapeutics, Inc. | 357.00M | 12.84% | 1,817,036 | 15.74M |
| 252 | AVTX | Avalo Therapeutics, Inc. | 349.26M | 9.68% | 495,417 | 192.00K |
| 253 | CLLS | Cellectis S.A. | 341.97M | -1.05% | 61,144 | 82.55M |
| 254 | MREO | Mereo BioPharma Group plc | 339.75M | 3.64% | 2,379,224 | 500.00K |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 336.63M | -3.27% | 740,371 | 33.98M |
| 256 | DRTS | Alpha Tau Medical Ltd. | 331.25M | -0.13% | 45,060 | - |
| 257 | SLN | Silence Therapeutics plc | 329.69M | 0.29% | 459,289 | 25.83M |
| 258 | LRMR | Larimar Therapeutics, Inc. | 326.53M | 3.11% | 833,361 | - |
| 259 | ALLO | Allogene Therapeutics, Inc. | 324.74M | 1.05% | 1,617,316 | 22.00K |
| 260 | NGNE | Neurogene Inc. | 320.33M | 1.97% | 209,711 | 925.00K |
| 261 | EPRX | Eupraxia Pharmaceuticals Inc. | 312.01M | -4.62% | 227,291 | - |
| 262 | GUTS | Fractyl Health, Inc. | 307.66M | 10.05% | 9,607,326 | 3.00K |
| 263 | RLMD | Relmada Therapeutics, Inc. | 304.33M | -2.12% | 883,045 | - |
| 264 | AARD | Aardvark Therapeutics, Inc. | 301.56M | 2.14% | 290,991 | - |
| 265 | CADL | Candel Therapeutics, Inc. | 298.65M | 2.06% | 888,052 | - |
| 266 | ALDX | Aldeyra Therapeutics, Inc. | 296.90M | 5.00% | 1,226,457 | - |
| 267 | TARA | Protara Therapeutics, Inc. | 293.78M | 1.97% | 1,436,446 | - |
| 268 | CYBN | Cybin Inc. | 292.93M | -2.00% | 700,522 | - |
| 269 | OABI | OmniAb, Inc. | 287.91M | 2.56% | 635,524 | 21.09M |
| 270 | ABEO | Abeona Therapeutics Inc. | 277.46M | 5.13% | 1,753,646 | 400.00K |
| 271 | ACIU | AC Immune SA | 275.56M | -0.54% | 263,921 | 5.48M |
| 272 | PBYI | Puma Biotechnology, Inc. | 271.61M | 1.70% | 383,228 | 212.00M |
| 273 | MIST | Milestone Pharmaceuticals Inc. | 270.21M | -0.75% | 4,565,237 | - |
| 274 | PALI | Palisade Bio, Inc. | 269.70M | 0.56% | 2,731,951 | - |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 261.45M | 1.97% | 219,425 | - |
| 276 | PYXS | Pyxis Oncology, Inc. | 260.26M | -0.95% | 474,003 | 2.82M |
| 277 | FENC | Fennec Pharmaceuticals Inc. | 259.23M | 0.53% | 86,405 | 38.79M |
| 278 | CBIO | Crescent Biopharma, Inc. | 257.86M | 0.92% | 131,244 | - |
| 279 | SLS | SELLAS Life Sciences Group, Inc. | 257.82M | 4.02% | 10,392,710 | - |
| 280 | FHTX | Foghorn Therapeutics Inc. | 252.78M | 2.52% | 96,650 | 24.52M |
| 281 | AVIR | Atea Pharmaceuticals, Inc. | 250.79M | 1.26% | 242,730 | - |
| 282 | ACHV | Achieve Life Sciences, Inc. | 249.67M | 1.52% | 540,028 | - |
| 283 | IMMP | Immutep Limited | 248.92M | 25.28% | 28,887,146 | 3.31M |
| 284 | HRTX | Heron Therapeutics, Inc. | 248.46M | 3.44% | 2,434,489 | 155.10M |
| 285 | CCCC | C4 Therapeutics, Inc. | 247.13M | -4.49% | 1,621,123 | 30.11M |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 246.75M | -0.68% | 137,891 | 2.82M |
| 287 | ZURA | Zura Bio Limited | 245.14M | 0.80% | 337,894 | - |
| 288 | HUMA | Humacyte, Inc. | 241.58M | 4.88% | 5,735,511 | 1.57M |
| 289 | VYGR | Voyager Therapeutics, Inc. | 240.75M | 1.17% | 502,797 | 31.32M |
| 290 | CABA | Cabaletta Bio, Inc. | 239.22M | -2.55% | 2,499,062 | - |
| 291 | MDWD | MediWound Ltd. | 237.32M | 4.69% | 200,723 | 20.93M |
| 292 | EDIT | Editas Medicine, Inc. | 235.26M | -0.41% | 1,085,031 | 46.38M |
| 293 | TNXP | Tonix Pharmaceuticals Holding Corp. | 235.12M | 1.65% | 475,650 | 10.30M |
| 294 | TNYA | Tenaya Therapeutics, Inc. | 230.61M | -1.77% | 1,546,255 | - |
| 295 | ETHZ | ETHZilla Corporation | 228.75M | 1.71% | 700,130 | 4.11M |
| 296 | PRQR | ProQR Therapeutics N.V. | 223.33M | 1.44% | 1,135,621 | 18.86M |
| 297 | QNCX | Quince Therapeutics, Inc. | 217.44M | -2.62% | 922,337 | - |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 211.82M | 4.56% | 875,271 | 97.60M |
| 299 | IMMX | Immix Biopharma, Inc. | 202.47M | 8.45% | 7,017,569 | - |
| 300 | SGMT | Sagimet Biosciences Inc. | 201.96M | -2.82% | 952,638 | - |
| 301 | ARMP | Armata Pharmaceuticals, Inc. | 201.27M | -1.60% | 59,422 | 5.05M |
| 302 | TLSA | Tiziana Life Sciences Ltd | 199.62M | -3.45% | 215,295 | - |
| 303 | NBY | NovaBay Pharmaceuticals, Inc. | 199.10M | 30.58% | 2,617,942 | 10.30M |
| 304 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 191.03M | 0.68% | 187,079 | - |
| 305 | STTK | Shattuck Labs, Inc. | 189.84M | -3.23% | 628,810 | 1.00M |
| 306 | RANI | Rani Therapeutics Holdings, Inc. | 188.95M | -2.20% | 1,873,171 | 1.20M |
| 307 | NTHI | NeOnc Technologies Holdings, Inc. | 179.16M | 0.33% | 38,671 | 59.99K |
| 308 | IPHA | Innate Pharma S.A. | 177.74M | 0.53% | 13,654 | 14.84M |
| 309 | CRBU | Caribou Biosciences, Inc. | 177.12M | -0.26% | 1,019,598 | 9.30M |
| 310 | ACTU | Actuate Therapeutics, Inc. | 177.11M | 3.67% | 85,357 | - |
| 311 | SRZN | Surrozen, Inc. | 174.86M | -0.29% | 110,177 | 3.60M |
| 312 | RNAC | Cartesian Therapeutics, Inc. | 174.48M | -2.47% | 137,367 | 1.09M |
| 313 | CDXS | Codexis, Inc. | 173.42M | 4.92% | 968,548 | 52.93M |
| 314 | ANIX | Anixa Biosciences, Inc. | 171.33M | 8.66% | 600,440 | - |
| 315 | NVCT | Nuvectis Pharma, Inc. | 169.83M | -1.19% | 74,160 | - |
| 316 | IKT | Inhibikase Therapeutics, Inc. | 169.82M | -3.33% | 253,777 | 1.00 |
| 317 | VOR | Vor Biopharma Inc. | 169.82M | 1.71% | 245,223 | - |
| 318 | CAMP | Camp4 Therapeutics Corporation | 169.24M | 11.08% | 165,101 | 3.80M |
| 319 | VTGN | Vistagen Therapeutics, Inc. | 169.04M | -1.15% | 748,018 | 721.00K |
| 320 | SGMO | Sangamo Therapeutics, Inc. | 168.11M | 0.75% | 3,939,212 | 32.88M |
| 321 | SABS | SAB Biotherapeutics, Inc. | 166.62M | -12.06% | 446,548 | 114.70K |
| 322 | GNLX | Genelux Corporation | 165.90M | -4.96% | 198,120 | 8.00K |
| 323 | IRD | Opus Genetics, Inc. | 158.62M | 1.32% | 179,439 | 14.63M |
| 324 | CRDF | Cardiff Oncology, Inc. | 157.96M | 11.14% | 1,889,841 | 501.00K |
| 325 | MOLN | Molecular Partners AG | 157.44M | 0.66% | 3,527 | 856.30K |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 155.54M | 2.25% | 1,415,063 | 70.00M |
| 327 | CGTX | Cognition Therapeutics, Inc. | 154.48M | 1.16% | 824,674 | - |
| 328 | SAVA | Cassava Sciences, Inc. | 154.34M | 0.16% | 492,169 | - |
| 329 | CHRS | Coherus Oncology, Inc. | 154.11M | 6.25% | 1,763,916 | 277.73M |
| 330 | MCRB | Seres Therapeutics, Inc. | 151.98M | 0.84% | 112,518 | 351.00K |
| 331 | INO | Inovio Pharmaceuticals, Inc. | 147.03M | 3.38% | 1,195,995 | 182.34K |
| 332 | ELTX | Elicio Therapeutics, Inc. | 146.79M | 5.00% | 66,266 | - |
| 333 | CGEN | Compugen Ltd. | 145.92M | 3.31% | 284,187 | 6.90M |
| 334 | GANX | Gain Therapeutics, Inc. | 144.60M | 3.64% | 1,967,647 | - |
| 335 | UNCY | Unicycive Therapeutics, Inc. | 141.74M | 5.86% | 454,592 | - |
| 336 | PLX | Protalix BioTherapeutics, Inc. | 139.93M | 0.58% | 463,521 | 61.84M |
| 337 | MRSN | Mersana Therapeutics, Inc. | 139.57M | 0.52% | 41,320 | 33.18M |
| 338 | AGEN | Agenus Inc. | 137.39M | 2.80% | 490,567 | 106.83M |
| 339 | CNTB | Connect Biopharma Holdings Limited | 135.29M | 0.83% | 127,740 | 762.00K |
| 340 | GLSI | Greenwich LifeSciences, Inc. | 133.83M | 8.05% | 92,972 | - |
| 341 | VRCA | Verrica Pharmaceuticals Inc. | 132.56M | -5.90% | 181,862 | 30.83M |
| 342 | ALEC | Alector, Inc. | 132.07M | -0.82% | 1,607,993 | 69.05M |
| 343 | ACOG | Alpha Cognition Inc. | 131.32M | -7.50% | 77,337 | 7.43M |
| 344 | NKTX | Nkarta, Inc. | 129.98M | 1.67% | 377,569 | - |
| 345 | SPRO | Spero Therapeutics, Inc. | 129.30M | 1.55% | 322,855 | 40.55M |
| 346 | COYA | Coya Therapeutics, Inc. | 127.43M | 1.16% | 262,676 | 3.99M |
| 347 | EXOZ | eXoZymes, Inc. | 125.81M | 1.87% | 1,079 | -700.00 |
| 348 | CLYM | Climb Bio, Inc. | 124.78M | 6.40% | 489,447 | - |
| 349 | FATE | Fate Therapeutics, Inc. | 123.43M | -0.93% | 874,716 | 7.14M |
| 350 | PRLD | Prelude Therapeutics Incorporated | 121.12M | 0.68% | 200,736 | 10.50M |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 119.86M | 0.95% | 933,259 | - |
| 352 | SLGL | Sol-Gel Technologies Ltd. | 117.00M | 3.70% | 6,783 | 18.97M |
| 353 | ABOS | Acumen Pharmaceuticals, Inc. | 116.91M | 3.76% | 81,528 | - |
| 354 | ANVS | Annovis Bio, Inc. | 114.76M | -4.84% | 910,470 | - |
| 355 | DTIL | Precision BioSciences, Inc. | 114.10M | -5.58% | 288,776 | 698.00K |
| 356 | KLRS | Kalaris Therapeutics, Inc. | 114.08M | 3.65% | 48,341 | - |
| 357 | WHWK | Whitehawk Therapeutics, Inc. | 113.34M | -3.41% | 162,964 | 14.38M |
| 358 | CNTX | Context Therapeutics Inc. | 112.98M | 0.95% | 664,617 | - |
| 359 | OVID | Ovid Therapeutics Inc. | 112.52M | -5.39% | 1,658,822 | 6.61M |
| 360 | ORMP | Oramed Pharmaceuticals Inc. | 109.06M | 1.86% | 57,465 | 2.00M |
| 361 | ATRA | Atara Biotherapeutics, Inc. | 108.15M | 4.68% | 52,217 | 151.93M |
| 362 | VANI | Vivani Medical, Inc. | 106.51M | 4.29% | 160,614 | - |
| 363 | SEER | Seer, Inc. | 103.77M | -1.06% | 181,582 | 16.38M |
| 364 | ZNTL | Zentalis Pharmaceuticals, Inc. | 103.68M | 3.24% | 1,108,371 | 26.87M |
| 365 | HURA | TuHURA Biosciences, Inc. | 101.75M | 2.32% | 122,022 | - |
| 366 | ONCY | Oncolytics Biotech Inc. | 100.93M | -4.15% | 594,145 | - |
| 367 | KPTI | Karyopharm Therapeutics Inc. | 100.43M | 2.43% | 148,610 | 142.53M |
| 368 | ATOS | Atossa Therapeutics, Inc. | 100.13M | -3.02% | 455,930 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 98.64M | -22.27% | 120,218 | - |
| 370 | ENTX | Entera Bio Ltd. | 97.68M | -0.93% | 24,559 | 124.00K |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 96.15M | 2.23% | 967,203 | 1.00M |
| 372 | BMEA | Biomea Fusion, Inc. | 95.45M | 10.66% | 1,937,738 | - |
| 373 | ADAG | Adagene Inc. | 93.32M | -0.50% | 18,899 | 103.20K |
| 374 | RPTX | Repare Therapeutics Inc. | 93.28M | -2.03% | 453,747 | 11.87M |
| 375 | ANEB | Anebulo Pharmaceuticals, Inc. | 91.62M | -1.33% | 32,517 | - |
| 376 | HYFT | MindWalk Holdings Corp. | 90.00M | -2.50% | 154,060 | 18.21M |
| 377 | FBIO | Fortress Biotech, Inc. | 89.54M | 1.94% | 252,170 | 62.30M |
| 378 | OTLK | Outlook Therapeutics, Inc. | 88.84M | -2.44% | 1,314,495 | 1.51M |
| 379 | VXRT | Vaxart, Inc. | 87.68M | 0.90% | - | 148.20M |
| 380 | THAR | Tharimmune, Inc. | 87.61M | 4.60% | 296,423 | - |
| 381 | CBUS | Cibus, Inc. | 87.40M | -1.83% | 87,009 | 3.79M |
| 382 | ACET | Adicet Bio, Inc. | 87.32M | 1.09% | 3,331,835 | - |
| 383 | PSTV | Plus Therapeutics, Inc. | 86.58M | -3.08% | 4,972,494 | 5.26M |
| 384 | SPRB | Spruce Biosciences, Inc. | 85.78M | 0.19% | 90,367 | 697.00K |
| 385 | CSBR | Champions Oncology, Inc. | 85.42M | 2.57% | 2,787 | 56.88M |
| 386 | TVGN | Tevogen Bio Holdings Inc. | 85.20M | 7.04% | 564,017 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 84.17M | 3.46% | 30,565 | 7.41M |
| 388 | MGNX | MacroGenics, Inc. | 83.82M | -3.28% | 3,060,849 | 127.63M |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 82.24M | -1.91% | 63,550 | 501.00K |
| 390 | BYSI | BeyondSpring Inc. | 81.01M | -1.01% | 15,117 | 1.88M |
| 391 | CRVO | CervoMed Inc. | 80.96M | 0.69% | 38,204 | 6.16M |
| 392 | IMUX | Immunic, Inc. | 80.87M | 1.16% | 722,357 | - |
| 393 | ATYR | aTyr Pharma, Inc. | 80.56M | -0.21% | 1,428,939 | 190.00K |
| 394 | ACRV | Acrivon Therapeutics, Inc. | 79.20M | 5.91% | 706,097 | - |
| 395 | PLRX | Pliant Therapeutics, Inc. | 78.66M | 5.79% | 2,215,656 | - |
| 396 | ALXO | ALX Oncology Holdings Inc. | 77.26M | 0.35% | 406,290 | - |
| 397 | ESLA | Estrella Immunopharma, Inc. | 77.04M | 2.51% | 94,639 | - |
| 398 | TIL | Instil Bio, Inc. | 75.96M | 2.56% | 91,756 | - |
| 399 | ARTV | Artiva Biotherapeutics, Inc. | 75.11M | -8.93% | 276,931 | 251.00K |
| 400 | MNOV | MediciNova, Inc. | 74.80M | -2.24% | 64,593 | 257.92K |
| 401 | XBIT | XBiotech Inc. | 73.78M | -2.42% | 75,991 | - |
| 402 | OKYO | OKYO Pharma Limited | 73.53M | 2.36% | 56,324 | - |
| 403 | IFRX | InflaRx N.V. | 72.83M | 1.42% | 613,505 | 73.73K |
| 404 | STRO | Sutro Biopharma, Inc. | 72.49M | -1.67% | 90,033 | 105.65M |
| 405 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 71.45M | 0.80% | 3,526,724 | - |
| 406 | KRRO | Korro Bio, Inc. | 71.01M | 7.41% | 413,211 | 7.37M |
| 407 | IMA | ImageneBio, Inc. | 69.34M | 0.62% | 43,367 | 800.00K |
| 408 | MGX | Metagenomi, Inc. | 68.71M | 2.81% | 269,169 | 30.91M |
| 409 | OSTX | OS Therapies Incorporated | 67.96M | 0.52% | 564,737 | - |
| 410 | PYPD | PolyPid Ltd. | 66.21M | 0.25% | 122,016 | - |
| 411 | ALGS | Aligos Therapeutics, Inc. | 66.09M | 7.51% | 59,123 | 2.65M |
| 412 | CALC | CalciMedica, Inc. | 65.13M | 3.43% | 202,576 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 64.91M | -5.26% | 31,895 | 3.57M |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 64.06M | -3.39% | 402,055 | 242.00K |
| 415 | SNTI | Senti Biosciences, Inc. | 63.62M | 13.62% | 175,210 | - |
| 416 | PMVP | PMV Pharmaceuticals, Inc. | 62.52M | -1.26% | 515,124 | - |
| 417 | LITS | Lite Strategy, Inc. | 62.17M | 1.20% | 269,696 | - |
| 418 | NTRB | Nutriband Inc. | 59.72M | 3.11% | 13,187 | 2.58M |
| 419 | TCRX | TScan Therapeutics, Inc. | 57.03M | -6.94% | 1,888,863 | 8.42M |
| 420 | INKT | MiNK Therapeutics, Inc. | 54.55M | 1.04% | 12,680 | - |
| 421 | INMB | INmune Bio, Inc. | 54.37M | 7.07% | 839,236 | 50.00K |
| 422 | IBO | Impact BioMedical Inc. | 54.27M | 13.25% | 1,157,172 | 25.00K |
| 423 | IOBT | IO Biotech, Inc. | 53.78M | 7.29% | 798,246 | - |
| 424 | CELU | Celularity Inc. | 53.26M | -5.05% | 47,514 | 40.58M |
| 425 | EQ | Equillium, Inc. | 53.25M | 2.59% | 51,107 | 4.39M |
| 426 | EVAX | Evaxion A/S | 51.89M | 19.05% | 311,001 | 7.65M |
| 427 | CVM | CEL-SCI Corporation | 51.34M | -0.70% | 54,787 | - |
| 428 | IPSC | Century Therapeutics, Inc. | 50.03M | 9.02% | 1,667,431 | 113.34M |
| 429 | ABVC | ABVC BioPharma, Inc. | 49.62M | -12.66% | 169,636 | 797.92K |
| 430 | ICCC | ImmuCell Corporation | 49.57M | -2.84% | 2,134 | 27.77M |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 49.03M | 6.13% | 361,664 | 1.14M |
| 432 | PDSB | PDS Biotechnology Corporation | 48.63M | 2.14% | 357,942 | - |
| 433 | BTAI | BioXcel Therapeutics, Inc. | 48.33M | 6.76% | 607,301 | 752.00K |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | 2.19% | 459,552 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 48.13M | 0.58% | 900,492 | - |
| 436 | BCAB | BioAtla, Inc. | 47.54M | -1.85% | 819,154 | 11.00M |
| 437 | OKUR | OnKure Therapeutics, Inc. | 46.88M | 13.07% | 380,115 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 46.62M | 2.48% | 64,244 | - |
| 439 | KZR | Kezar Life Sciences, Inc. | 45.77M | - | 23,607 | - |
| 440 | MAIA | MAIA Biotechnology, Inc. | 45.73M | 2.92% | 488,602 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 44.30M | -0.70% | 138,607 | 90.00K |
| 442 | LTRN | Lantern Pharma Inc. | 43.17M | 2.93% | 50,891 | - |
| 443 | GNTA | Genenta Science S.p.A. | 42.88M | -2.14% | 53,269 | - |
| 444 | VERU | Veru Inc. | 42.53M | 6.43% | 159,254 | 16.89M |
| 445 | QTTB | Q32 Bio Inc. | 42.45M | 3.92% | 800,017 | - |
| 446 | CUE | Cue Biopharma, Inc. | 40.86M | -5.45% | 335,426 | 7.10M |
| 447 | NXTC | NextCure, Inc. | 40.25M | -3.69% | 111,843 | - |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 39.50M | 0.72% | 110,074 | - |
| 449 | SKYE | Skye Bioscience, Inc. | 39.43M | 2.50% | 197,740 | - |
| 450 | JUNS | Jupiter Neurosciences, Inc. | 39.25M | - | 36,901 | - |
| 451 | QNTM | Quantum BioPharma Ltd. | 38.88M | 0.80% | 33,804 | - |
| 452 | RADX | Radiopharm Theranostics Limited | 38.73M | -5.26% | 10,138 | 8.20M |
| 453 | XLO | Xilio Therapeutics, Inc. | 38.33M | -0.03% | 1,257,395 | 31.80M |
| 454 | IBIO | iBio, Inc. | 37.78M | 40.00% | 112,030,947 | 500.00K |
| 455 | APLM | Apollomics, Inc. | 36.48M | 4.49% | 28,923 | 198.00K |
| 456 | GBIO | Generation Bio Co. | 36.38M | 1.31% | 41,748 | 15.27M |
| 457 | DYAI | Dyadic International, Inc. | 36.10M | 5.00% | 159,755 | 3.34M |
| 458 | RNTX | Rein Therapeutics Inc. | 36.01M | 0.74% | 62,364 | - |
| 459 | SER | Serina Therapeutics, Inc. | 35.83M | 3.38% | 8,660 | 116.00K |
| 460 | ANL | Adlai Nortye Ltd. | 35.11M | -5.80% | 33,095 | 1.94M |
| 461 | RNXT | RenovoRx, Inc. | 34.63M | 0.38% | 147,696 | 928.00K |
| 462 | GLTO | Galecto, Inc. | 34.61M | -5.03% | 150,073 | - |
| 463 | FGEN | FibroGen, Inc. | 34.26M | 0.59% | 14,683 | 8.30M |
| 464 | XCUR | Exicure, Inc. | 33.59M | 7.55% | 67,482 | 500.00K |
| 465 | LNAI | Lunai Bioworks Inc. | 32.57M | 11.20% | 507,941 | - |
| 466 | KLTO | Klotho Neurosciences, Inc. | 31.94M | -12.12% | 1,965,063 | - |
| 467 | APLT | Applied Therapeutics, Inc. | 31.88M | 1.99% | 3,306,982 | 1.00M |
| 468 | PASG | Passage Bio, Inc. | 30.36M | 3.69% | 61,387 | - |
| 469 | INTS | Intensity Therapeutics, Inc. | 30.15M | -1.57% | 4,910,805 | - |
| 470 | ANTX | AN2 Therapeutics, Inc. | 30.14M | - | 79,726 | - |
| 471 | PLUR | Pluri Inc. | 29.01M | -4.42% | 18,659 | 1.33M |
| 472 | KZIA | Kazia Therapeutics Limited | 29.00M | 5.02% | 255,372 | 1.20M |
| 473 | RLYB | Rallybio Corporation | 28.55M | 2.13% | 234,821 | 674.00K |
| 474 | BRNS | Barinthus Biotherapeutics plc | 28.27M | -4.02% | 84,855 | 14.97M |
| 475 | NRXS | NeurAxis, Inc. | 27.97M | -1.65% | 32,016 | 3.36M |
| 476 | ENLV | Enlivex Therapeutics Ltd. | 27.21M | -7.44% | 1,468,480 | - |
| 477 | NERV | Minerva Neurosciences, Inc. | 27.13M | 1.04% | 22,328 | - |
| 478 | IGC | IGC Pharma, Inc. | 26.87M | -2.89% | 436,199 | 1.11M |
| 479 | HYPD | Hyperion DeFi, Inc. | 26.57M | -4.63% | 177,529 | 345.32K |
| 480 | CING | Cingulate Inc. | 26.22M | -2.76% | 93,827 | - |
| 481 | DARE | Daré Bioscience, Inc. | 26.01M | 2.25% | 80,940 | -57.13K |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 25.60M | -0.32% | 10,247 | 2.48M |
| 483 | NNVC | NanoViricides, Inc. | 25.56M | 15.45% | 1,081,196 | - |
| 484 | MTVA | MetaVia Inc. | 25.43M | - | 2,318,324 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 25.31M | - | 881,904 | - |
| 486 | BOLD | Boundless Bio, Inc. | 25.29M | -0.88% | 170,403 | - |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.59M | 6.42% | 97,632 | - |
| 488 | NRSN | NeuroSense Therapeutics Ltd. | 24.54M | -16.25% | 809,998 | - |
| 489 | NEUP | Neuphoria Therapeutics Inc. | 24.31M | 5.85% | 37,666 | 15.65M |
| 490 | LEXX | Lexaria Bioscience Corp. | 24.12M | 2.36% | 88,413 | 705.92K |
| 491 | LIMN | Liminatus Pharma, Inc. | 23.71M | 4.40% | 209,674 | - |
| 492 | ITRM | Iterum Therapeutics plc | 23.65M | -5.06% | 618,303 | 390.00K |
| 493 | MRKR | Marker Therapeutics, Inc. | 23.51M | 6.82% | 488,605 | 4.69M |
| 494 | PLRZ | Polyrizon Ltd. | 22.46M | -13.13% | 1,224,613 | - |
| 495 | APVO | Aptevo Therapeutics Inc. | 22.41M | -1.48% | 534,774 | - |
| 496 | PTN | Palatin Technologies, Inc. | 22.39M | -8.04% | 31,105 | 8.85M |
| 497 | GDTC | CytoMed Therapeutics Limited | 21.58M | 5.65% | 318,459 | 573.19K |
| 498 | BCTX | BriaCell Therapeutics Corp. | 21.47M | 8.87% | 49,398 | - |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 20.87M | -4.24% | 337,185 | - |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 20.81M | -1.52% | 26,514 | - |
| 501 | OSRH | OSR Holdings, Inc. | 19.23M | 1.90% | 642,902 | -90.52K |
| 502 | CASI | CASI Pharmaceuticals, Inc. | 19.19M | -2.74% | 52,986 | 26.85M |
| 503 | KAPA | Kairos Pharma, Ltd. | 18.32M | -1.11% | 66,631 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 18.15M | -2.50% | 115,323 | - |
| 505 | ALLR | Allarity Therapeutics, Inc. | 18.10M | 0.44% | 108,075 | - |
| 506 | LPCN | Lipocine Inc. | 17.88M | 2.22% | 8,332 | 4.32M |
| 507 | NCNA | NuCana plc | 17.40M | 0.24% | 44,541 | - |
| 508 | TRAW | Traws Pharma, Inc. | 17.34M | -5.24% | 147,026 | 2.85M |
| 509 | LSTA | Lisata Therapeutics, Inc. | 17.29M | -0.51% | 19,643 | 1.07M |
| 510 | PMN | ProMIS Neurosciences, Inc. | 17.22M | 1.20% | 15,534 | - |
| 511 | CRIS | Curis, Inc. | 17.20M | -1.48% | 81,664 | 11.65M |
| 512 | FBLG | FibroBiologics, Inc. | 16.89M | 4.47% | 1,364,770 | - |
| 513 | NCEL | NewcelX Ltd. | 16.87M | 1.65% | 142,421 | - |
| 514 | CMMB | Chemomab Therapeutics Ltd. | 16.87M | 10.48% | 104,414 | - |
| 515 | CLRB | Cellectar Biosciences, Inc. | 16.41M | 2.65% | 73,113 | - |
| 516 | SNGX | Soligenix, Inc. | 15.99M | -1.55% | 403,107 | 2.34K |
| 517 | CANF | Can-Fite BioPharma Ltd. | 15.80M | 2.46% | 462,036 | 560.00K |
| 518 | PCSA | Processa Pharmaceuticals, Inc. | 15.76M | 0.07% | 731,322 | - |
| 519 | TPST | Tempest Therapeutics, Inc. | 15.52M | 0.96% | 98,944 | - |
| 520 | ABP | Abpro Holdings, Inc. | 15.51M | -1.72% | 15,945 | 183.00K |
| 521 | ATHA | Athira Pharma, Inc. | 15.44M | -0.91% | 3,347 | - |
| 522 | BCDA | BioCardia, Inc. | 15.18M | 4.38% | 83,475 | 3.00K |
| 523 | MBRX | Moleculin Biotech, Inc. | 14.80M | 0.41% | 814,206 | - |
| 524 | BLRX | BioLineRx Ltd. | 14.52M | -1.18% | 43,251 | 12.74M |
| 525 | COCP | Cocrystal Pharma, Inc. | 14.47M | 2.94% | 73,753 | - |
| 526 | PULM | Pulmatrix, Inc. | 14.43M | -3.19% | 23,179 | 3.00K |
| 527 | DWTX | Dogwood Therapeutics, Inc. | 13.58M | -1.50% | 13,971 | - |
| 528 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.86M | 26.80% | 392,130 | - |
| 529 | LGVN | Longeveron Inc. | 12.66M | -3.48% | 495,912 | 1.44M |
| 530 | ICU | SeaStar Medical Holding Corporation | 12.64M | -2.48% | 1,966,856 | 881.00K |
| 531 | VYNE | VYNE Therapeutics Inc. | 12.50M | 1.51% | 372,201 | 524.00K |
| 532 | EDSA | Edesa Biotech, Inc. | 12.39M | - | 30,606 | - |
| 533 | SYBX | Synlogic, Inc. | 12.28M | 1.94% | 25,767 | 8.00K |
| 534 | PHIO | Phio Pharmaceuticals Corp. | 12.11M | -14.12% | 998,626 | - |
| 535 | GOVX | GeoVax Labs, Inc. | 12.09M | 7.96% | 1,274,988 | 3.35M |
| 536 | AKTX | Akari Therapeutics, Plc | 11.97M | -1.18% | 161,922 | - |
| 537 | IMRN | Immuron Limited | 11.96M | -1.66% | 231,981 | 4.78M |
| 538 | IMNN | Imunon, Inc. | 11.85M | -1.03% | 34,795 | - |
| 539 | BIVI | BioVie Inc. | 11.76M | -1.27% | 37,685 | - |
| 540 | PPCB | Propanc Biopharma, Inc. | 11.21M | -0.06% | 38,812 | - |
| 541 | APM | Aptorum Group Limited | 10.75M | - | 26,099 | - |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 10.61M | -0.68% | 64,227 | - |
| 543 | SNSE | Sensei Biotherapeutics, Inc. | 10.36M | -15.53% | 77,743 | - |
| 544 | ERNA | Ernexa Therapeutics Inc. | 10.28M | -0.76% | 32,150 | 1,000.00 |
| 545 | BOLT | Bolt Biotherapeutics, Inc. | 10.21M | -1.85% | 23,012 | 5.20M |
| 546 | ASBP | Aspire Biopharma Holdings, Inc. | 9.82M | -0.11% | 7,851,502 | 1.94K |
| 547 | BRTX | BioRestorative Therapies, Inc. | 9.68M | -1.80% | 26,495 | 383.40K |
| 548 | SLXN | Silexion Therapeutics Corp | 9.50M | 0.66% | 27,046 | - |
| 549 | EVGN | Evogene Ltd. | 9.40M | 3.60% | 20,724 | 8.02M |
| 550 | ACXP | Acurx Pharmaceuticals, Inc. | 9.15M | 36.76% | 690,274 | - |
| 551 | MBIO | Mustang Bio, Inc. | 9.12M | - | 60,570 | - |
| 552 | TCRT | Alaunos Therapeutics, Inc. | 9.08M | 12.74% | 68,644 | 6.00K |
| 553 | AEON | AEON Biopharma, Inc. | 8.91M | 12.04% | 172,574 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 8.69M | 0.43% | 23,377 | 6.00K |
| 555 | ALZN | Alzamend Neuro, Inc. | 8.52M | -0.44% | 29,882 | - |
| 556 | BGMS | Bio Green Med Solution, Inc. | 8.28M | 1.81% | 23,310 | 81.00K |
| 557 | INAB | IN8bio, Inc. | 8.25M | 0.56% | 25,226 | - |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 8.20M | - | 44,129 | 451.00K |
| 559 | GRDX | GridAI Technologies Corp. | 8.07M | - | 45,474 | - |
| 560 | PMCB | PharmaCyte Biotech, Inc. | 7.92M | -4.51% | 2,269,835 | - |
| 561 | ADXN | Addex Therapeutics Ltd | 7.73M | 2.29% | 674 | 198.82K |
| 562 | GNPX | Genprex, Inc. | 7.72M | 1.19% | 218,512 | - |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 7.63M | 2.46% | 12,425 | 20.00K |
| 564 | RNAZ | TransCode Therapeutics, Inc. | 7.60M | -3.72% | 7,364 | - |
| 565 | TOVX | Theriva Biologics, Inc. | 7.52M | -1.20% | 1,894,888 | - |
| 566 | ADIL | Adial Pharmaceuticals, Inc. | 7.24M | -2.14% | 160,175 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 7.01M | -7.49% | 47,706 | 600.00K |
| 568 | GTBP | GT Biopharma, Inc. | 6.90M | 6.51% | 1,057,407 | - |
| 569 | PPBT | Purple Biotech Ltd | 6.89M | -3.61% | 144,758 | - |
| 570 | CYCN | Cyclerion Therapeutics, Inc. | 6.78M | 5.95% | 128,001 | 2.86M |
| 571 | KALA | KALA BIO, Inc. | 6.65M | -10.00% | 5,086,104 | - |
| 572 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.65M | -0.27% | 37,337 | 15.78K |
| 573 | APRE | Aprea Therapeutics, Inc. | 6.63M | -0.94% | 126,686 | 488.24K |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 6.58M | 7.14% | 353,082 | - |
| 575 | REVB | Revelation Biosciences, Inc. | 6.22M | 1.45% | 71,617 | - |
| 576 | SILO | Silo Pharma, Inc. | 6.04M | 3.40% | 99,781 | 72.10K |
| 577 | VIVS | VivoSim Labs, Inc. | 6.00M | -0.86% | 48,662 | 140.00K |
| 578 | ENSC | Ensysce Biosciences, Inc. | 5.78M | -3.05% | 68,390 | 4.49M |
| 579 | XBIO | Xenetic Biosciences, Inc. | 5.64M | -2.77% | 26,257 | 2.86M |
| 580 | MTNB | Matinas BioPharma Holdings, Inc. | 5.53M | 9.18% | 60,841 | - |
| 581 | HCWB | HCW Biologics Inc. | 5.40M | 1.01% | 70,329 | 422.03K |
| 582 | BDRX | Biodexa Pharmaceuticals Plc | 5.23M | 67.66% | 13,704,882 | 104.90K |
| 583 | PHGE | BiomX Inc. | 4.84M | -38.68% | 795,966 | - |
| 584 | SLRX | Salarius Pharmaceuticals, Inc. | 4.81M | -0.48% | 396,919 | - |
| 585 | CNSP | CNS Pharmaceuticals, Inc. | 4.64M | 13.33% | 22,193 | - |
| 586 | JAGX | Jaguar Health, Inc. | 4.63M | 4.63% | 130,923 | 11.79M |
| 587 | ONCO | Onconetix, Inc. | 4.57M | 13.79% | 27,299 | 1.22M |
| 588 | INDP | Indaptus Therapeutics, Inc. | 4.55M | 4.00% | 39,782 | - |
| 589 | GRI | GRI Bio, Inc. | 4.40M | -34.71% | 2,230,998 | - |
| 590 | XRTX | XORTX Therapeutics Inc. | 4.21M | 2.79% | 48,437 | - |
| 591 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.14M | 0.43% | 31,662 | 1.36M |
| 592 | OGEN | Oragenics, Inc. | 3.96M | 7.46% | 110,626 | - |
| 593 | AZTR | Azitra, Inc. | 3.92M | 5.90% | 302,634 | 7.50K |
| 594 | SCNI | Scinai Immunotherapeutics Ltd. | 3.83M | - | 23,450 | 1.15M |
| 595 | ENVB | Enveric Biosciences, Inc. | 3.62M | -10.75% | 57,145 | - |
| 596 | ARTL | Artelo Biosciences, Inc. | 3.55M | -4.35% | 151,670 | - |
| 597 | VRAX | Virax Biolabs Group Limited | 3.54M | -14.02% | 1,385,070 | 2.99K |
| 598 | ELAB | PMGC Holdings Inc. | 3.50M | -5.24% | 4,275,673 | 285.95K |
| 599 | SPRC | SciSparc Ltd. | 3.26M | 15.52% | 1,134,108 | 1.31M |
| 600 | PBM | Psyence Biomedical Ltd. | 3.24M | -1.70% | 101,318 | - |
| 601 | PTIX | Protagenic Therapeutics, Inc. | 3.23M | - | 180,455 | - |
| 602 | CDT | CDT Equity Inc. | 3.13M | 7.26% | 276,768 | - |
| 603 | DRMA | Dermata Therapeutics, Inc. | 2.88M | 0.36% | 573,592 | - |
| 604 | CMND | Clearmind Medicine Inc. | 2.47M | -7.28% | 6,828,501 | - |
| 605 | ADTX | Aditxt, Inc. | 1.90M | 10.39% | 1,033,487 | 5.95K |
| 606 | MLEC | Moolec Science SA | 1.70M | -9.27% | 72,440 | 7.83M |